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Introduction
Von Hippel-Lindau (VHL) disease is a hereditary cancer syn-
drome characterized by a spectrum of benign and malignant   
tumors, including hemangioblastomas, pheochromocytomas, 
and clear cell renal cell carcinomas (ccRCCs). Patients with VHL 
disease inherit a faulty allele of the ubiquitously expressed VHL 
tumor suppressor gene, and emergence of pathology in these pa-
tients follows the inactivation of the remaining wild-type allele. 
Biallelic inactivation of the VHL gene also occurs frequently 
(50–75%) in nonhereditary cancers, in particular sporadic ccRCC, 
the most common form of kidney cancer.
In humans, the VHL gene is expressed in long (pVHL30) 
and short (pVHL19) isoforms of 30 kD and 19 kD, respectively 
(generically referred to as pVHL; Iliopoulos et al., 1998). pVHL 
has been ascribed multiple functions, each possibly linked to   
tumor suppression (Frew and Krek, 2008). Widely accepted, 
pVHL acts as part of an E3 ubiquitin ligase that targets hypoxia-
inducible  factor  (HIF)    subunits  for  polyubiquitylation  in   
an oxygen-dependent manner (Kaelin and Ratcliffe, 2008). 
In VHL-defective cancers, the HIF transcriptional program is 
uncoupled from changes in oxygen availability, leading to over-
production of HIF target gene products involved in promoting 
tumor growth. This pVHL function is differentially compro-
mised by VHL mutations linked to VHL disease, which causes 
mutation-specific variations in disease phenotype (Kaelin, 2008). 
Specifically, disease-associated VHL alleles are subdivided into 
type 1 (low risk of pheochromocytoma) and type 2 (high risk of 
pheochromocytoma) disease mutations, with type 2 further sub-
divided into type 2A (low risk of renal cell carcinoma), type 2B   
(high risk of renal cell carcinoma), and type 2C (pheochromo-
cytoma only). Type 1 disease is associated with large dele-
tions that affect multiple pVHL functions, including the ability 
V
on Hippel-Lindau (VHL) tumor suppressor gene 
mutations predispose carriers to kidney cancer. 
The protein pVHL has been shown to interact with 
microtubules (MTs), which is critical to cilia maintenance and 
mitotic spindle orientation. However, the function for pVHL   
in the regulation of MT dynamics is unknown. We tracked 
MT growth via the plus end marker EB3 (end-binding 
protein 3)-GFP and inferred additional parameters of   
MT dynamics indirectly by spatiotemporal grouping of 
growth tracks from live cell imaging. Our data establish 
pVHL as a near-optimal MT-stabilizing protein: it attenuates 
tubulin turnover, both during MT growth and shrinkage, 
inhibits catastrophe, and enhances rescue frequencies. 
These functions are mediated, in part, by inhibition of   
tubulin guanosine triphosphatase activity in vitro and at MT 
plus ends and along the MT lattice in vivo. Mutants con-
nected to the VHL cancer syndrome are differentially com-
promised in these activities. Thus, single cell–level analysis 
of pVHL MT regulatory function allows new predictions for 
genotype to phenotype associations that deviate from the 
coarser clinically defined mutant classifications.
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catastrophe and rescue by shifting the rate of GTP hydrolysis 
along the MT lattice and at the cap.
To examine pVHL’s regulatory functions as a MAP and 
to test whether phenotypic variation at the level of the cancer 
syndrome associated with different VHL point mutations would 
correlate with phenotypic variation at the level of MT dynamics, 
we computationally tracked a large number of MT growth events 
in high-resolution live cell images via the plus end marker EB3 
(end-binding protein 3)-GFP. We then applied a recently devel-
oped method for spatiotemporal grouping of growth tracks to ex-
tract additional parameters of MT dynamic instability. Our results 
suggest that pVHL is a near-optimal MT-stabilizing protein in 
that it lowers MT turnover and enhances MT stability by reduc-
ing catastrophe and increasing rescue frequencies. We mechanis-
tically link these functions of pVHL to the inhibition of tubulin 
GTPase activity in vitro and in vivo and demonstrate that they are 
subject to specific alterations by disease-causing VHL mutations. 
Thus, quantitative differences between distinct pVHL mutants 
with respect to MT dynamic instability regulation may translate 
into different risks of renal carcinoma in humans.
Results
Automated tracking of MT growth using 
the plus end marker EB3 establishes pVHL 
as an attenuator of MT growth
To systematically manipulate the conditions of pVHL expression, 
we used retinal pigment epithelial (RPE-1) cells and knocked down 
endogenous levels of wild-type pVHL by transfection of silenc-
ing microRNA-based small hairpin RNA (shRNA [shRNAmir]; 
Fig. 1 A). Conversely, renal cell carcinoma (RCC-4) cells defi-
cient for pVHL were engineered to stably produce either long or 
short pVHL isoforms (pCMV(R)-VHL30 and pCMV(R)-VHL19, 
respectively; Iliopoulos et al., 1998) or the empty vector as control 
(pCMV(R)-VHL
/; Fig. 1 B). The same cell system was used   
to investigate the specific effects on MT dynamics of naturally 
occurring point mutants of pVHL.
Following our previous observations that pVHL protects 
MTs  from  nocodazole-induced  depolymerization  (Hergovich 
et al., 2003), we first tested whether the presence and absence 
of pVHL have a global effect on the density of MTs. Indeed, 
the normalized immunofluorescence of MTs was increased 
by 40% after reconstitution of wild-type pVHL30 in VHL- 
deficient RCC-4 cells (Fig. 1, C and D), suggesting that pVHL 
stabilizes MTs. However, the effect was relatively mild (P < 0.02).   
Thus, we suspected that the roles ascribed to pVHL in sev-
eral MT-dependent cell functions would be more related to its   
effects on parameters of MT dynamic instability.
MT dynamic instability is an intrinsically stochastic process. 
Therefore, distributions with hundreds to thousands of values have 
to be sampled to permit undistorted and significant comparisons 
between MT behaviors in the presence or absence of pVHL or 
in association with the expression of different mutants (Jaqaman   
et al., 2006). To collect unbiased statistics of the dynamics of many 
MTs, we expressed in both RPE-1 and RCC-4 cells a GFP fusion 
construct of EB3 and applied a recently developed method for   
the detection and tracking of EB3-GFP comets (Fig. 1 E and 
to regulate HIF-. Type 2 disease is almost invariably linked 
to VHL missense mutations. pVHL mutants linked to type 2A 
and type 2B VHL disease share an inability to properly regulate 
HIF, albeit to a different degree (Li et al., 2007), implying that 
these VHL mutations quantitatively alter the ability of pVHL to 
regulate HIF-. pVHL mutants associated with type 2C disease 
seem to retain the ability to target HIF for degradation (Hoffman 
et al., 2001), suggesting that other pVHL functions are affected 
in this setting. Together, these findings support the view that 
VHL missense mutations impact the integrity of several distinct 
functions of pVHL, thus modifying the risk of developing the 
complex pathologies associated with the VHL cancer syndrome. 
Therefore, it is critically important to determine the degree to 
which various functions of pVHL are quantitatively altered by 
different VHL mutations.
Among the HIF-independent functions, pVHL has been 
shown to bind to microtubules (MTs) along the entire lattice and   
to protect them from disassembly upon treatment of cells with   
the MT-depolymerizing drug nocodazole (Hergovich et al., 2003).   
This function, which appears to be independent of E3 ubiq-
uitin ligase activity, is compromised by type 2A but not type 2B 
VHL mutations. The significance of pVHL’s role as an MT- 
associated protein (MAP) derives from the observation that pVHL 
is important for primary cilia maintenance and protection from 
kidney cyst formation, in part by stabilizing MTs or orienting 
MT growth (Schermer et al., 2006; Thoma et al., 2007; Frew   
et al., 2008), as well as for the suppression of spindle mis-
orientation (Thoma et al., 2009). This implies that pVHL’s tumor 
suppressor function is licensed, at least in part, through inter-
actions with MTs. Although these qualitative linkages between 
pVHL and MTs are intriguing, it remains unknown which as-
pects of MT regulation are affected by VHL disease mutants and 
whether there are quantitative differences among mutants. Such 
information is indispensable for understanding the molecular 
basis of the differential risks of kidney cancer linked to distinct 
VHL mutations.
At steady-state, MTs continually switch between phases   
of growth and shrinkage, a phenomenon known as dynamic in-
stability (Mitchison and Kirschner, 1984). Transitions from growth 
to shrinkage are referred to as catastrophe events, and transitions 
from shrinkage to growth are referred to as rescue events. High-
resolution measurements of MT length trajectories both in vitro 
and in vivo have also indicated that growth and shrinkage phases 
are intermitted by pauses (Keller et al., 2007). Dynamic instabil-
ity is generally associated with the variable state of GTP nucleo-
tides bound to the tubulin dimers in the MT lattice (Weisenberg 
et al., 1976). Growing MTs are thought to have at their tip a cap 
of two to three layers of GTP-tubulin that stabilizes the polymer 
and increases the affinity for additional GTP-tubulin assembly 
(Mitchison and Kirschner, 1984; Schek et al., 2007). Catastro-
phe events may be induced when GTP hydrolysis is temporarily 
higher than the rate of dimer addition, resulting in abrogation of the 
stabilizing GTP cap. Evidence suggests that during polymeriza-
tion, GTP hydrolysis is incomplete, producing GTP remnants 
along the MT polymer that may facilitate rescue events (Dimitrov   
et al., 2008). This hypothesis is intriguing as it proposes a mech-
anism by which MAPs may equally alter the frequencies of 993 pVHL regulates microtubule dynamic instability • Thoma et al.
Figure 1.  pVHL attenuates MT growth rate. 
(A) RPE-1 cell system and depletion of pVHL 
using retroviral expression (pLMP-EB3GFP) of 
shRNAmir  against  VHL  (shVHL)  and  a  non-
silencing  control  (ns-control).  (B)  RCC-4  cell 
system lacking pVHL expression reconstituted 
with  retroviral  expression  (pCMV(R))  of  the 
wild-type  long  form  pVHL30,  the  wild-type 
short form pVHL19, and the empty vector as 
control (VHL
/). Vertical black lines indicate 
that intervening lanes have been spliced out.   
(A and B) Molecular mass is indicated in kilo-
daltons. (C) Immunofluorescence analysis of MT 
mass in RCC-4 cells expressing the wild-type 
long form pVHL30 or the empty vector (VHL
/). 
I
Tub,rel  indicates  the  -tubulin  signal  intensity 
normalized  to  GSK-3  signal.  (D)  Relative   
-tubulin signal as measured in C. Data were 
pooled from n = 3 slides, each slide with 10 
stacks of five frames each per condition. Mean ±   
SD is shown (*, P < 0.02). (E) Single frame 
of a video acquired from RPE-1 cells express-
ing  EB3-GFP.  Red  marks  indicate  automatic 
detection of EB3-GFP comets. (F) Mean near-
est neighbor distance between EB3-GFP com-
ets in RCC-4 cells (n = 15) expressing pVHL30 
or the empty vector (VHL
/). Box plot indi-
cates distribution of n = 15 cells. (G) Over-
lay to frame in E of EB3-GFP tracks over 125 
frames sampled at 0.5 s/frame. Track color 
encodes speed. (E and G) Zoom panels rep-
resent enlargements of the boxed areas in the 
left panels. (H) Distributions of growth speed 
of  >55,000  tracked  EB3-GFP  comets  in  12 
RPE-1 cells (left) and of per cell means (right). 
Comparison  of  growth  speed  distributions 
was based on Kolmogorov-Smirnov test, and 
comparison of per cell means was based on 
the Student’s t test after validation of normality 
(***, P < 10
5; see Materials and methods). 
(I) Distributions of growth speed of all tracked 
EB3-GFP comets (left) and of per cell means 
(right) in RCC-4 cells (***, P < 10
5). See leg-
end for H for statistical test procedures. (F, H, 
and I) Boxes indicate 25, 50 (median), and 
75% quantiles; whiskers extend to 1.5× the 
interquartile range; red dots indicate outliers 
beyond this range. Notched boxes indicate un-
certainty of the median. Boxes whose notches 
do not overlap indicate that the medians of the 
two clusters differ at the 5% significance level.   
Bars: (C) 10 µm; (E and G) 5 µm.JCB • VOLUME 190 • NUMBER 6 • 2010   994
presence of pVHL at the MT tip may sterically interfere with 
dimer-recruiting factors. Alternatively, pVHL may bind to tubu-
lin dimers and thus slow down the incorporation. The latter sce-
nario would cause pVHL to affect only the growth rate, whereas 
the former would likely be coupled to pVHL-mediated changes 
in other parameters of MT dynamic instability. Therefore, MT 
dynamics  had  to  be  characterized  beyond  the  instantaneous 
growth speeds reported by EB3-GFP particles. EB3-GFP par-
ticles disappear from the image when the MT switches from a 
state of growth into a state of shrinkage, i.e., undergoes a catas-
trophe. They also disappear during MT pauses that last longer 
than the time it takes EB3 aggregates to dissociate from the tip 
or because the growing MT tip moves out of focus. In the sce-
nario of a pause, the EB3-GFP particle may reappear near the 
site of disappearance, indicating the reinitiation of MT growth 
after pausing. In the scenario of out of focus movement, the par-
ticle may reappear in the flight of the terminated track. In both   
scenarios, the new track has a high probability of being col-
linear with the terminated track. In the scenario of a track termina-
tion caused by catastrophe, a new track may be observed if the   
shrinking MT is later rescued. The site of track reinitiation has a 
high probability of being located near the axis of the terminated 
track in the direction opposite to the previous particle motion.
Accounting for the different scenarios of particle appear-
ances, we spatially and temporally grouped tracks that belonged 
to the same MT with a high probability (Fig. 2 A and Fig. S3). 
About  70%  of  the  growth  tracks  participated  in  multitrack   
trajectories that linked visible EB3 growth tracks with forward 
and/or reverse gaps (Fig. 2 B and Videos 3 and 4). The validity 
of this approach has been established previously using multi-
spectral live cell images of EB3 comets and tubulin-labeled MTs 
(Matov et al., 2010). Excellent agreement was found between 
hand-tracked and computationally tracked growth and shrink-
age speeds. In the present study, we repeated the validation by 
comparing manually tracked MT ends in RPE-1 cells express-
ing GFP-tubulin with computer-generated growth and shrink-
age speeds in EB3-GFP–expressing RPE-1 cells (Tables S1 and 
S2). Although the data show again good agreement between 
the shrinkage speeds, the computer-tracked growth speeds are 
faster. This is caused by regional effects. MTs at the cell pe-
riphery, where manual tracking of continuously stained MTs 
is possible, tend to grow slower than MTs in the perinuclear 
area (Matov et al., 2010). Direct comparison of the durations of 
growth, shrinkage, and pause phases is not possible. In trajecto-
ries of continuously stained MTs, the transitions between these 
phases are defined by arbitrary speed thresholds distinguishing 
growth and shrinkage from pausing. In multitrack trajectories 
of EB3 comets, the transition between these phases is defined 
by the disappearance and reappearance of detectable particles. 
Nevertheless, in Matov et al. (2010), it was established that 
qualitative changes in these parameters between different ex-
perimental conditions are reflected equally by both measure-
ment approaches. This was confirmed in the present study using 
RPE-1 cells. With silencing VHL, the pause times decreased 
and the shrinkage times increased, both with manual and com-
putational tracking, whereas growth times remained unchanged 
(Fig. S1 E and Tables S1 and S2).
Videos 1 and 2; Matov et al., 2010). For each condition, 12–15 
videos of 125 frames were acquired in three independent ses-
sions at 2-Hz frame rate. EB3 transiently binds to growing MT 
plus ends (Stepanova et al., 2003), generating a punctuate pattern 
of EB3-GFP comets throughout the cell. Each video contained 
30,000–40,000 detectable comets, from which >500 informa-
tive MT growth tracks with a lifetime of more than three frames 
were extracted. Tracks existing for three frames or less had a sig-
nificant probability of representing random connections between 
false detection positives. In agreement with the overall slightly 
higher density of MTs in VHL-expressing cells as compared with 
cells without pVHL, we found that upon reconstitution of wild-
type pVHL30 in VHL-deficient RCC-4 cells, the density of EB3 
comets was slightly increased, as observed by a reduction of the 
mean nearest neighbor distance between comets (Fig. 1 F). Again, 
the statistical significance of this effect was weak (P = 0.11), in-
dicating that effects of pVHL on the overall MT mass and on the 
density of growing MT ends are minor.
The  measured  MT  growth  track  speeds  (mean  velocity   
over the duration of a track) varied remarkably (Fig. 1, G and H). 
In RPE-1 cells, the 25% and 75% quartiles were at 10.1 µm min
1 
and 18.6 µm min
1, respectively, and 6% of the tracks reached 
values 30–60 µm min
1. Validation of these tracks by visual in-
spection suggested that some of them were caused by erroneous 
frame to frame links between detected particles and thus outliers 
to the speed distribution. However, because of the large pool of 
speed measurements, the low percentage of data outliers had no 
marked effect on the comparison of MT growth track speeds be-
tween different experimental conditions. Depletion of pVHL in 
RPE-1 cells did not significantly alter the shape of growth track 
speed distribution (P = 0.56, Kolmogorov-Smirnov test). How-
ever, the mean growth speed increased significantly from 15.4 ± 
1.1 to 17.8 ± 1.0 µm min
1 (mean ± SD of cell to cell variation; 
n = 13). These results indicated that pVHL dampens MT growth 
overall without differentially affecting the heterogeneous behav-
iors of MTs throughout the cell.
We first validated this finding by manual tracking of 20 
MTs in RPE-1 cells stably expressing GFP-tubulin (Fig. S1, A–E; 
and Table S1). Second, we repeated our analysis in RPE-1 cells   
without and with knockdown of pVHL expression based on GFP-
CLIP170, an alternative marker of growing MT plus ends (Fig. S1, 
F and G; Perez et al., 1999). Both experiments confirmed the 
broad range of MT growth rates but underlined the function of 
pVHL as attenuator of MT growth. Third, we sought to substanti-
ate this role of pVHL by comparing VHL-deficient RCC-4 cells 
with those producing pVHL30 or pVHL19 (Fig. 1 I). Interest-
ingly, although both isoforms reduced the growth speed, pVHL19 
yielded a significantly milder effect than pVHL30, suggesting 
that pVHL interferes with the recruitment and/or incorporation of   
tubulin dimers to the MT plus end in an isoform-specific manner.
Geometric grouping of growth tracks 
allows extraction of additional parameters 
of MT dynamics and reveals pVHL as an 
attenuator of MT shrinkage
There are several mechanisms by which pVHL may reduce 
the rate of tubulin addition to the plus end. For example, the 995 pVHL regulates microtubule dynamic instability • Thoma et al.
cells without and with depletion of pVHL, respectively. The re-
sult that these two numbers are statistically indistinguishable 
for conditions with and without pVHL suggests that pVHL does 
not significantly interfere with the formation of EB3 particles. 
This conclusion was further confirmed by colocalization analy-
sis of EB3 comets and pVHL, indicating that pVHL does not 
preferentially overlap with growing MT ends (Fig. S2).
The growth segment speed is defined by the distance be-
tween the site of initiation of the first growth track and the site 
of termination of the last growth track in a sequence of multiple 
growth tracks linked by forward gaps only, divided by the time 
elapsed between the initiation and termination event (Fig. 2 A). 
The shrinkage speed is defined by the distance between the sites 
of termination and reinitiation of two growth tracks connected 
in backward direction divided by the time elapsed without   
an EB3 particle (Fig. 2 A). Because of the latency in the EB3 
We first examined the effect of pVHL on the gap/pause 
speed, the growth segment speed, and the shrinkage speed   
(Table S2). The gap/pause speed is defined by the distance between 
the sites of termination and reinitiation of two growth tracks 
connected in forward direction divided by the time elapsed with-
out an EB3 particle (Fig. 2 A). Although the gap/pause speeds 
were substantially lower than growth track speeds, they were 
different from zero. Analysis of the speed distributions showed 
that <15% were >10.1 µm min
1, i.e., the 25–100% range of 
the growth track speed distribution. This minority of forward 
gaps was likely to represent temporary out of focus movements, 
whereas the majority of gaps corresponded to bona fide pauses. 
The nonzero speed of these gaps originates in the latency of 
formation of a detectable EB3-GFP particle after growth of a 
pausing MT is resumed. The mean latency could be estimated 
as  ∆ = ∆ × t t v v lat gap gap growth,  i.e., 2.3 s and 2.2 s for RPE-1 
Figure 2.  Clustering of EB3-GFP growth tracks reveals pVHL’s function as an attenuator of MT shrinkage rate. (A) Clustered EB3-GFP tracks with cor-
responding head to tail tracks, forward gap closure (gap/pause event), and reverse gap closure (shrinkage event) are shown. A series of tracks and forward 
gap closures not interrupted by a reverse gap closure is referred to as a growth segment. A circle shows the first detected EB3-GFP signal of a track, and 
asterisks define the last signal of a track in the corresponding color. Growth track speeds (vm, vo, and vr) are defined as the head to tail distance of the track 
divided by its lifetime (m, o, and r frames, respectively); gap/pause speed (vn) is defined as the distance between the termination point and the initiation 
point of the two linked growth tracks divided by the forward gap duration (n frames); accordingly, growth segment speed (vs) is defined by the distance 
of the entire growth segment divided by the sum of lifetimes of all included growth tracks and forward gap closures (m + n + o frames); shrinkage speed 
(vp) is defined as the distance between the termination point and the initiation point of the two linked growth tracks divided by the reverse gap duration   
(p frames). (B) Example of clustered growth tracks in a video acquired from RPE-1 cells. Color codes as in A. (C) Analysis of MT dynamics in n = 12 RPE-1 
cells (Fig. 1 A). Distributions of gap/pause speeds of >23,000 forward gap closures (top) and of per cell mean (bottom), distributions of growth segment 
speeds of >14,000 growth segments (top) and of per cell mean (bottom), and distributions of shrinkage speeds of >10,000 reverse gap closures and per 
cell mean are shown (***, P < 10
5). (D) Analysis of MT dynamics in n = 10 RCC-4 cells (Fig. 1 B). Distributions of MT gap/ pause speeds of >12,000 
forward gap closures (top) and of per cell mean (bottom), distributions of growth segment speeds of >8,000 growth segments (top) and of per cell mean   
(bottom), and distributions of shrinkage speeds of >5,000 reverse gap closures and per cell mean from 10 cells are shown (*, P < 5 × 10
2; ***, P < 10
5).   
(C and D) Boxes indicate 25, 50 (median), and 75% quantiles; whiskers extend to 1.5× the interquartile range; red dots indicate outliers beyond this 
range. Notched boxes indicate uncertainty of the median. Boxes whose notches do not overlap indicate that the medians of the two clusters differ at the 
5% significance level. See Materials and methods for statistical test procedures.JCB • VOLUME 190 • NUMBER 6 • 2010   996
Acute perturbation of MT polymerization 
dynamics by nocodazole reveals the 
inhibition of MT catastrophe and the 
promotion of rescue as two additional 
functions of pVHL
To elucidate in more mechanistic terms the finding of pVHL-
mediated protection of MTs from nocodazole-induced depoly-
merization (Hergovich et al., 2003), we treated RCC-4 cells 
with substoichiometric concentrations of nocodazole (40 nM) 
and measured over 6 min after perfusion the transient effects on 
EB3-GFP particle dynamics (Table S4). As expected, nocodazole 
caused increased particle disappearance over time, yet cells 
with reconstituted pVHL30 expression exhibited a lower decay 
in particle number (Fig. 3 A and Video 5). Consistent with data 
from hand-measured, continuously labeled MTs (Vasquez et al., 
1997), EB3 particles reported gradual slowing after nocodazole 
treatment of both growth speeds, as measured by track velocities, 
and shrinkage speeds, as inferred from the distance and duration 
of reverse gaps (Fig. 3 B). The decrease of both speeds was sup-
pressed by the expression of pVHL30. Although it cannot be ruled 
out that pVHL30 interferes with the binding of nocodazole to   
tubulin dimers, these data favor a model in which pVHL30 weak-
ens interactions between nocodazole and the MT end (Vasquez   
et al., 1997). Surprisingly, expression of pVHL30 had no effect on 
the speed reduction of either segments or forward gaps (Fig. 3,   
C and D). Given the differential decrease in track speeds, this 
suggested differential pausing behaviors of MTs under the chal-
lenge of nocodazole in the absence and presence of pVHL30.   
Indeed, we found that the fraction of growth segment time spent 
in forward gaps increased in the presence of pVHL30, whereas 
it remained unaffected in the absence of pVHL30 (Fig. 3 E).   
At the same time, the duration of growth segments significantly 
decreased in the absence of pVHL30, whereas segment duration 
particle formation as well as the possibility that the MT pauses 
throughout the shrinkage phase, the shrinkage speed extracted from 
linking growth tracks tends to underestimate the instantaneous rate 
of disassembly of MTs. Nevertheless, significant changes in the 
characteristics of MT disassembly between different conditions 
will be detected by this parameter (Matov et al., 2010).
As shown in Fig. 2 C, although the shape of the distribu-
tions of gap/pause speed, growth segment speed, and shrinkage 
speed showed again no differences (top), depletion of pVHL in 
RPE-1 cells caused an increase in the mean of all three speeds 
(bottom). Thus, these data confirm pVHL’s role as an attenuator 
of MT assembly and suggest that pVHL also lowers the rate of 
subunit dissociation during shrinkage. This supports a model in 
which pVHL is active at the MT tip and along the lattice as op-
posed to the free tubulin dimer. In agreement with our findings 
in RPE-1 cells, reconstitution of the long and the short isoforms 
of pVHL in VHL-negative RCC-4 cells attenuated all three addi-
tional speed parameters (Fig. 2 D). Interestingly, even though we 
found isoform-specific attenuation of the growth track speeds 
(Fig. 1 G), the growth segment speeds of pVHL19 and pVHL30 
did not differ (Fig. 2 D). This adjustment was not caused by a 
difference in the gap/pause speeds (Fig. 2 D) but was related to 
prolonged pauses and shortened growth phases of MTs in cells 
expressing the short isoform (Table S3). Thus, although both 
isoforms attenuated the growth and shrinkage speeds of MTs, 
we found that the short isoform was less efficient in attenuation 
but inhibited more strongly the reinitiation of MT growth after 
pauses. This notion is further supported by the fact that >40% 
of  all  growth  segments  in  cells  expressing  the  long  isoform 
were composed of at least three growth tracks, i.e., had two or 
more growth reinitiations after pausing, whereas 60% reinitiated 
growth only once. When expressing the short isoform, this ratio 
dropped to 30:70.
Figure 3.  pVHL enhances MT growth recovery under nocodazole challenge. (A) Relative loss of EB3-GFP signal after the addition of 40 nM nocodazole 
to RCC-4 cells reconstituted with the empty retroviral expression vector pCMV(R) (VHL
/) or with pCMV(R) expressing wild-type pVHL (VHL30). (B) Relative 
slowdown of growth and shrinkage speeds. (C) Relative slowdown of growth segment speeds. (D) Relative slowdown of gap/pause speeds. (E) Change in 
the frequency of gaps. (F) Relative change in the duration of segments.997 pVHL regulates microtubule dynamic instability • Thoma et al.
of the growth segment speeds measured in RCC-4 cells express-
ing pVHL30(wt) (Table S5). Thus, similar to the short isoform 
pVHL19(wt), the type 2B mutant pVHL30(G114S) affected the 
instantaneous MT growth but produced globally equal growth 
rates because MTs spent less time growing and more time paus-
ing (Table S5), which is distinct from type 2B mutant Y98N. 
Furthermore, like the short isoform, the pVHL30(G114S) mu-
tant induced intermediate attenuation of MT shrinkage between 
complete loss of pVHL function and wild-type behavior (Fig. 4 B).   
These  results  suggest  that  defects  in  pVHL’s  MT  regulatory 
functions are not solely associated with type 2A but also with 
certain type 2B mutants, however with intermediate effects.
Catastrophe inhibition and rescue are 
coupled functions of VHL
To learn more about potentially differential defects in the various 
pVHL mutants in terms of their function as catastrophe inhibitors 
and rescue factors, we next focused on shrinkage events, cap-
tured by reverse gaps between EB3 growth tracks. These covered   
16–32% of the overall duration of multitrack trajectories (Fig. 4 C, 
horizontal axis). At the lower end of this range, RCC-4 cells pro-
ducing the long form pVHL30(wt) clustered with mutants that had 
wild-type behavior with respect to speed attenuation. These include 
the type 2B pVHL30 mutants R167W and Y98N. At the inter-
mediate level, RCC-4 cells producing the short form pVHL19(wt), 
the type 2B mutant G114S, and the type 2C mutant L188V were clus-
tered. Like pVHL19(wt), these two mutants also displayed an inter-
mediate increase in speed attenuation (Fig. 4 B). At the upper end, 
VHL-negative RCC-4 cells and the type 2A mutant pVHL30(Y98H), 
which exhibited complete loss of function with respect to speed   
attenuation, as well as the type 2B mutant pVHL30(R161P), which 
retained, unlike the other species within this cluster, speed   
attenuation function, were clustered. Interestingly, mutants 
stayed almost constant for the period of 6 min in the presence of 
pVHL30 (Fig. 3 F). Together, these data suggest that under the 
challenge of nocodazole, MTs in VHL-deficient RCC-4 cells in-
creasingly underwent catastrophe. Reconstitution of VHL30 sta-
bilized these events in pauses from which MT growth could be 
recovered. Thus, we conclude that besides attenuation of tubulin 
turnover at the MT end, VHL30 takes a second set of roles as a 
catastrophe inhibitor and rescue factor.
Naturally occurring point mutants with 
different disease phenotypes exhibit 
differential defects in attenuating tubulin 
turnover at growing and shrinking MT ends
To further investigate the dualism of pVHL function in control-
ling MT dynamics in the context of the VHL cancer syndrome, 
we generated a panel of RCC-4 cell lines, each producing a differ-
ent naturally occurring point mutant of pVHL30 that is associ-
ated with a distinct VHL disease phenotype, including types 2A, 
2B, and 2C (Fig. 4 A and Table S5). We hypothesized that this 
disease-based classification may have a correlate in differential 
impairments of the two MT-related functions of pVHL. Immuno-
blotting for pVHL revealed that each mutant protein is produced, 
albeit at slightly different amounts (Fig. S4 A). This is not un-
expected given the different inherited protein stabilities associ-
ated with these mutations (Knauth et al., 2006, 2009). As shown 
in Fig. 4 B, the type 2A mutant pVHL30(Y98H) was dysfunc-
tional in attenuating growth and shrinkage speeds, whereas the 
corresponding type 2B mutant pVHL30(Y98N) displayed wild-
type behavior with respect to reducing tubulin turnover at the   
MT ends. Interestingly, another type 2B mutant, pVHL30(G114S), 
was impaired in attenuation of tubulin turnover, as seen by   
elevated growth track and shrinkage speeds. However, the 
growth segment speed produced by this mutant was at the level 
Figure 4.  Analysis of naturally occurring pVHL point mutants. (A) Position of each naturally occurring point mutation within pVHL30 domains and its dis-
ease class. pVHL19 results from an internal translational initiation site at methionine 54 (M54). (B) Distributions of per cell means of growth track and shrink-
age speeds (10–15 RCC-4 cells per mutant). The light blue line indicates the median value of RCC-4 cells expressing wild-type pVHL30, and the red line 
indicates the median value of RCC-4 cells expressing the control vector (Figs. 1 I and 2 D). The speeds distributions of individual MT growth and shrinkage 
events are presented in Fig. S4 B. Boxes indicate 25, 50 (median), and 75% quantiles; whiskers extend to 1.5× the interquartile range; red dots indicate 
outliers beyond this range. Notched boxes indicate uncertainty of the median. Boxes whose notches do not overlap indicate that the medians of the two 
clusters differ at the 5% significance level. (C) Scatter plot of shrinkage probability (probability of a switch from a growth to a shrinkage event) versus time 
spent in shrinkage, relative to the total duration of trajectories.JCB • VOLUME 190 • NUMBER 6 • 2010   998
coupled functions of pVHL as a catastrophe inhibitor and res-
cue factor could be explained by its effect on GTPase activity.
To test this directly, we determined the frequency and local-
ization of GTP-tubulin by immunostaining in the presence and 
absence of pVHL30 and of the various naturally occurring point 
mutants of pVHL30. As shown in Fig. 5 B, when we analyzed the 
frequency of GTP-tubulin signals at the MT tips, we observed 
a significant reduction of signals in VHL-negative RCC-4 cells 
compared with those expressing wild-type pVHL30. RCC-4 cells 
producing the short isoform pVHL19 displayed an intermediate 
frequency of capped MT tips, but this is statistically insignificant 
because of the limited sampling. Most intriguingly, the frequency 
of GTP caps in cells expressing various disease-causing pVHL30 
mutants revealed a highly significant correlation with the shrink-
age  probabilities  inferred  by  geometric  grouping  of  plus  end 
marker growth tracks (Fig. 5 C). First, these results confirm the 
accuracy of the grouping method in detecting shrinkage events. 
Second, they support the hypothesis that by interfering with tu-
bulin GTPase activity, pVHL stabilizes MTs in part via reduction 
of catastrophe events.
Next, we determined whether pVHL would also influ-
ence the distances between GTP-tubulin remnants along the 
MT lattice in vivo, as it was suggested before that this distance 
is  inversely  proportional  to  the  rescue  frequency  (Dimitrov   
et al., 2008). Indeed, in support of our conclusion from live cell 
imaging that pVHL is a rescue factor, we observed a reduc-
tion of the distance between GTP-tubulin remnants by 35% 
in  pVHL30-producing  RCC-4  cells  compared  with  control 
RCC-4 cells devoid of pVHL (Fig. 5 D), whereas expression 
of the short isoform pVHL19 caused an intermediate reduction 
of the distance between GTP remnants along the MT lattice   
(Fig. 5 D). GTP remnant distances in RCC-4 cells expressing 
point mutants of pVHL30 revealed excellent correlation between 
the distances between GTP-tubulin remnants along the MT lat-
tice and the relative time in shrinkage (Fig. 5 E). Again, this 
validates the inference of rescue frequencies from grouped MT 
growth tracks. Two representative immunofluorescence pictures 
of RCC-4 control cells and RCC-4 cells producing wild-type 
pVHL30  costained  with  antibodies  against  tubulin  and  GTP-
tubulin exemplify these observations (Fig. 5 F). Because GTP 
remnant distances could only be measured on peripheral MTs, 
we  additionally  measured  the  relative  intensity  of  the  GTP- 
tubulin signal in perinuclear regions. This analysis also revealed 
significantly higher signal intensity in cells expressing pVHL30 
compared  with VHL-negative  cells  (Fig.  5  G).  Collectively, 
these results suggest a mechanism for pVHL’s function to lower 
catastrophe rates and to enhance rescue rates: wild-type pVHL 
has the capacity to reduce the intrinsic GTPase activity of tubu-
lin. Thereby, it increases the fraction of GTP-capped MT tips, 
which in turn inhibits MT catastrophe events. It also increases 
the frequency of GTP remnants along the MT lattice in vivo. 
Assuming that these remnants are preferred sites of MT res-
cue (Dimitrov et al., 2008), the shorter distances between rem-
nants explain the higher probability for rescue. The reduction of   
GTPase activity is partially or fully impaired by point mutations in 
VHL, accompanied by a corresponding impairment of the pVHL 
gene product to act as a catastrophe inhibitor or rescue factor.
generally showed a tight positive correlation between the time 
spent in shrinkage and the probability of an MT to transition from 
a growth track into a reverse gap (Fig. 4 C). Thus, increased shrink-
age time is associated with a higher rate of catastrophe events, sug-
gesting that pVHL’s functions as a catastrophe inhibitor and as a 
rescue factor are coupled. The exception to these rules was again 
the type 2B mutation pVHL30(R161P). In contrast to the other 
type 2B mutations, this one is located in the Elongin C–binding   
domain of pVHL and therefore impaired the formation of a func-
tional VHL–Elongin  B–Elongin  C–Cul2  complex  (Ohh  et  al., 
1999). MTs in cells expressing this mutant had a probability of 
switching from growth tracks into reverse gaps above the general 
trend line (Fig. 4 C). Consistent with an abnormally high catastro-
phe rate for pVHL30(R161P), the fraction of EB3 growth tracks 
participating in multitrack trajectories dropped from a range of 
65–72% to 48% (Table S5), suggesting that in cells expressing this 
mutant, a significant fraction of catastrophe events are terminal. 
Another mutant defective in Elongin C binding, pVHL30(R167W) 
(Kishida et al., 1995), did not exhibit such a behavior. These analy-
ses pinpoint that the two MT-regulatory functions of pVHL are 
differentially perturbed in disease-causing mutants and that cur-
rent clinically defined genotype to phenotype associations are in-
complete in distinguishing quantitative functional defects related 
to point mutations in different domains of the VHL gene product. 
Moreover, given that pVHL30(R161P) and pVHL30(R167W) mu-
tant proteins are defective in targeting HIF- subunits and are 
associated with a high risk of ccRCC, they suggest that certain 
VHL mutations that are linked to ccRCC development are defec-
tive in more than one distinct biochemical activity, which may 
profoundly influence the path of renal pathology in the setting of 
VHL disease.
Catastrophe inhibition and increased 
rescue are both promoted by pVHL-
dependent reduction in GTP hydrolysis 
activity of MTs
To shed light on the biochemical mechanism by which VHL may 
affect MT polymerization dynamics, we asked whether pVHL 
would alter the rate of MT GTP hydrolysis in vitro. Indeed, in 
the presence of active pVHL30, the rate of tubulin GTP hydrolysis 
was lower. This effect strictly depended on the ability of pVHL 
to bind MTs because the presence of pVHL30(95–123), a mu-
tant lacking the MT interaction domain (Hergovich et al., 2003), 
failed to lower GTP hydrolysis (Fig. 5 A). The purity of the GST 
fusion proteins for the GTPase assay is documented in Fig. S5.
To extend this observation to an in vivo setting, we took 
advantage  of  an  antibody  that  specifically  recognizes  GTP- 
tubulin.  Using  this  antibody,  it  has  been  demonstrated  that 
GTP-tubulin localizes not only at the MT tip but that remnants 
of GTP-tubulin can also be found along the entire MT lattice 
(Dimitrov et al., 2008). The study proposes that such remnants 
could serve as sites of rescue events for shrinking MTs. From 
these data, it follows that factors lowering the overall GTPase 
rate may increase the occurrence of GTP-tubulin caps at MT tips 
and thus reduce the frequency of catastrophe. At the same time, 
these factors may increase the occurrence of remnants along the 
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from well-controlled growth to well-controlled shrinkage; and 
(d) if the switch occurs, it enhances the probability for returning 
into a growth state.
A mechanistic explanation for pVHL’s dual roles as a catas-
trophe inhibitor and rescue factor is provided by its inhibitory 
action on GTPase activity of tubulin in vitro, which translates 
into  a  measurable  higher  frequency  of  GTP-tubulin  remnants 
along the MT lattice and on MT plus ends in vivo. Although we   
Discussion
Based on our results, we propose that pVHL functions as a MAP 
with dedicated MT-stabilizing function: (a) it dampens addition 
of tubulin dimers in growth, thus avoiding depletion of the pool 
of free tubulin dimers; (b) it dampens the removal of tubulin 
dimers during shrinkage, thus avoiding rapid, catastrophic dis-
assembly of parts of the MT network; (c) it limits the switches 
Figure 5.  pVHL reduces intrinsic GTPase activity of MTs, resulting in higher frequencies of GTP caps and GTP remnants along the MT lattice. (A) MAP-
purified tubulin was incubated with GST-VHL30, GST-VHL30(95–123), or GST. Release of free 
32P from -[
32P]GTP was measured at the indicated time 
points. Error bars represent SD of n = 9 or n = 3 independent measurements for GST and GST-VHL30 or GST-VHL30(95–123), respectively (GST vs. GST-
VHL30(95–123), NS; *, P = 0.04 and 0.01 [60 min]; *, P = 0.003 and 0.0007 [90 min]; *, P = 7 × 10
5 and 0.01 [180 min]; Student’s t test [GST vs. 
GST-VHL30 and GST-VHL30(95–123) vs. GST-VHL30]). (B) Frequency of GTP-capped MTs in RCC-4 cells expressing no VHL (VHL
/), wild-type long form 
(VHL30), or wild-type short form (VHL19). Mean ± SD is shown (***, P = 3.3 × 10
7). (C) Scatter plot of shrinkage probability (see legend for Fig. 4 C) to 
GTP cap frequency (percentage of GTP-capped MTs) in RCC-4 cells expressing various naturally occurring VHL point mutants (Fig. 4 A; mean of n = 12 
cells from three independent stainings, a total of >250 measurements per condition; Spearman correlation). (D) Distance between GTP-tubulin remnants in 
RCC-4 cells expressing no VHL (VHL
/), wild-type long form (VHL30), or wild-type short form (VHL19; mean ± SD of n = 12 cells from three independent 
stainings; *, P = 0.03; ***, P = 3.4 × 10
6). (E) Scatter plot of relative time in shrinkage (see legend for Fig. 4 C) to GTP remnant distance in RCC-4 cells 
expressing various naturally occurring VHL point mutants (Fig. 4 A; mean of n = 12 cells from three independent stainings, a total of >500 measurements 
per condition; Spearman correlation). (F) Immunofluorescence costaining with anti–-tubulin (green) and anti–GTP-tubulin (red) of RCC-4 cells reconstituted 
with VHL30 or the empty vector as control (VHL
/). Zoomed areas (right) are indicated by a dashed square in the panels to the left. Yellow arrows show 
GTP-capped MTs. Red lines indicate perinuclear area where the GTP remnant signal was measured. Bars: (left) 10 µm; (right) 2 µm. (G) GTP remnant signal 
intensity relative to tubulin intensity of RCC-4 cells reconstituted with VHL30 or the empty vector as control (VHL
/; mean ± SD of n = 9 cells from three 
independent stainings; *, P < 0.05; Student’s t test).JCB • VOLUME 190 • NUMBER 6 • 2010   1000
patterns of MT dynamic instability influence the path of disease in 
the setting of the VHL cancer syndrome. For example, ccRCC de-
velopment in the context of the type 2B pVHL mutants R161P and 
G114S may be cyst dependent and in the case of pVHL mutants 
R167W and Y98N cyst independent. Such a new subclassification 
of type 2B VHL disease that is based on patterns of altered MT dy-
namic instability may ultimately also profoundly impact treatment 
of VHL-associated cancers. Clearly, future whole-animal studies   
using knockin mice with the corresponding mutants will be required 
to test these predictions from a single-cell assay of MT dynamics.
Finally, these experiments demonstrate that the sensitiv-
ity of computer-based live cell readouts is becoming capable of 
identifying subtle implications of individual protein domains on 
cell function in vivo. The practical simplicity of our assay can 
bring high-content in situ live cell measurements of MT dy-
namics into the realm of high-resolution screening applications. 
This approach can significantly expand our knowledge on the 
physiology of MTs and their roles in disease as well as allow 
the identification of new anticancer agents that target distinct 
aspects of MT dynamics.
Materials and methods
Cloning of vectors
For the generation of retroviral VHL expression plasmids pCMV(R)-neo and 
pBabe-neo, the fragments were subcloned by digestion of corresponding 
pcDNA3-HA-VHL vectors that have been described previously (Hergovich 
et al., 2003) using BamHI–XhoI fragments for pCMV(R)-neo and BamHI–
EcoRI fragments for pBabe-neo. The BamHI–Xho1 fragments were subse-
quently blunted using mung bean nuclease and ligated into pCMV(R)-neo 
vector linearized with EcoRV. The BamHI–EcoRI fragments were ligated 
into pBabe-neo vector linearized with BamHI–EcoRI.
The  pLMP-EB3GFP  vector  was  cloned  by  PCR  amplification  of  the  EB3GFP 
fragment from the vector pGFP-N1-EB3 (gift from N. Galjart, Erasmus Medical 
Center, Rotterdam, Netherlands) using an N-terminal primer introducing a PciI 
site (5-CGTGACATGTATGGCAGTGAATGTGTACTCTACGTCAGTCACC-3) 
and a C-terminal primer introducing a SalI site (5-GTACCGTCGACTTACTT-
GTACAGCTCGTCCATGC-3). The PCR fragment was purified and digested 
with PciI and SalI and ligated into pLMP (gift from S. Lowe, Cold Spring 
Harbor Laboratory, Cold Spring Harbor, NY) linearized with NcoI and SalI. 
The cloning of the VHL-targeting (shVHL) and the nonsilencing (ns-control) 
shRNAmir into pLMP-EB3GFP have been described previously (Hergovich   
et al., 2006). pCMV-NEO-ZEO was cloned as described previously (Frew   
et al., 2008). The cloning of the VHL-targeting and the ns-control shRNAmir into 
pCMV-NEO-ZEO was performed as for the pLMP-EB3GFP vector. Transient 
expression of pGFP-N1-EB3 and pGFP-C1-CLIP170 in RPE-1 cells (gift from   
F. Perez, Institut Curie, Paris, France) was performed with Fugene 6 (Roche) 
according to the manufacturer’s manual.
Generation and maintenance of cell lines
RCC-4 cells (provided by P. Maxwell, University College London, London, 
England, UK) were infected with retroviral vectors pCMV(R)-neo or pBabe-
neo to express the different VHL mutants as described previously (Thoma 
et al., 2007). To express EB3-GFP, RCC-4 cells expressing VHL mutant 
proteins were super-infected with the retroviral vector pLMP-EB3GFP as   
described previously (Thoma et al., 2007). RPE-1 cells were infected with 
the retroviral vector pLMP-shRNAmir-EB3GFP expressing additionally an   
ns-control or a VHL-targeting shRNAmir as described previously (Thoma et al., 
2007). RCC-4 cells were cultured in DME 10% FCS, RPE-1 cells were cul-
tured in DME/F12 10% FCS. In RPE-1 cells expressing either GFP-CLIP170 
or GFP–-tubulin, pVHL was depleted using stable lentiviral transfection 
(pCMV-NEO-ZEO) of shRNAmir against VHL (shVHL) and a nonsilencing 
control (ns-control) as described previously (Frew et al., 2008).
Western blots
Cells were lysed in TNN buffer (25 mM Tris-HCl, pH 7.2, 150 mM Na chlo-
ride, 10% glycerol, 1% NP-40, 10 mM Na fluoride, 1 mM Na3VO4, 1 mM 
PMSF, 1 mM dithiothreitol, and 10 µg/ml aprotinin) for protein extraction. 
cannot formally exclude the possibility that regulation of GTPase   
activity by pVHL is also implicated in pVHL-mediated con-
trol of MT turnover, MT stability and turnover are differentially   
affected by naturally occurring pVHL mutants, implying that 
they represent separable activities of pVHL.
We also found that different VHL disease mutants were 
associated with profound differences in their ability to regulate 
various parameters of MT dynamic instability. From clinical work 
(Crossey et al., 1994; Chen et al., 1995), genotype–phenotype 
correlations have emerged with respect to the organ-specific 
risk of tumor development in VHL disease. All VHL mutations 
linked to classical VHL disease have been found to compromise 
pVHL’s HIF- regulatory function. However, some missense 
mutations result in a low risk of kidney cancer (type 2A VHL 
disease), whereas others result in a high risk (type 2B VHL dis-
ease). Therefore, it is still not fully understood why type 2A and 
type 2B VHL mutations are associated with markedly different 
risks of developing renal carcinoma. Quantitative differences 
between the ability of these various pVHL mutants to target 
HIF- may provide part of the explanation (Li et al., 2007). 
Our ability to quantitatively assess various parameters of MT 
dynamic instability allowed us to provide potential explana-
tions for the different phenotypes. We found that type 2A pVHL 
mutants are compromised in their ability to lower the speed of   
tubulin turnover both at growing and shrinking MT ends, as well 
as in inhibiting catastrophe and enhancing rescue events. Thus, 
these missense mutations behave with respect to MT regula-
tion equivalent to VHL-negative cells, except that type 2A VHL 
disease mutations are less defective in HIF- control and are 
not associated with a high risk of developing renal carcinoma. 
However, type 2A VHL disease is characterized by renal cyst 
formation, implying an explicit link between the disruption of 
multiple parameters of MT dynamic instability and the develop-
ment of a hallmark feature of the VHL cancer syndrome. Based 
on these observations, we propose a model in which cyst forma-
tion in type 2A VHL disease occurs as the result of disruption 
of MT regulation by pVHL in the absence of any quantitative 
differences in HIF- regulation.
Our analysis of different type 2B pVHL mutants, which 
have all been previously shown to be defective in HIF degra-
dation (Li et al., 2007), revealed striking differences with re-
spect to the regulation of MT dynamic instability parameters. 
Specifically, the pVHL mutant R161P displays defects in MT 
stabilization but not turnover function. In contrast, the mutant 
G114S is disrupted in MT turnover but not stabilization func-
tion. Moreover, the pVHL mutants, R167W and Y98N, behaved 
like wild-type pVHL with respect to MT regulation. Thus, 
distinct VHL mutations associated with type 2B VHL disease 
commonly compromise the ability of pVHL to regulate HIF but 
generate different patterns of MT dynamic instability. Given 
these observations, the fact that ccRCC is a common clinical 
endpoint of all type 2B VHL disease mutations (Kondo et al., 
2002; Gallou et al., 2004) and that these mutations are all de-
fective in HIF- degradation, it is conceivable that the specific 
pattern of altered MT dynamic instability produced by various 
type 2B VHL disease mutations characterize distinct subgroups 
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and C++. The algorithms for each of the steps are described in detail in 
Matov et al. (2010). The same paper documents the validation of each 
of the steps in reference to simultaneously acquired time-lapse sequences   
of mCherry-tubulin–labeled MTs and GFP-EB1 and in reference to well-
characterized small molecule inhibitors of MT polymerization dynamics. 
Together with the comparison of hand measurements and automated image 
analysis of the effects of silencing pVHL in RPE-1 cells, and with the agree-
ment between the conclusions drawn from the distribution of GTP remnants 
and the image analysis provided in this study, the tests conducted in Matov 
et al. (2010) established the validity of the analysis of MT regulatory func-
tions of pVHL based on live cell images of a plus end marker.
In brief, EB3 comet detection is accomplished by band-pass filter-
ing, which enhances image features of the expected size of an EB3 comet 
while it oppresses higher-frequency noise and lower-frequency structures 
representing larger aggregates of fluorescent protein. Importantly, the algo-
rithm is robust against variations in comet lengths, both within videos and 
between videos. Within videos, EB3 comets differ in length mainly because 
of the variable speed of MT growth. Between videos, EB3 comets differ in 
length because of variable EGFP-EB3 expression levels. The feature detector 
delivers not only the position of each comet in a frame but also the eccen-
tricity and orientation of the comets. The latter is used as a directional cue 
in the subsequent tracking of comets from one frame to the next.
Frame to frame tracking is performed by solving a linear assignment 
problem (LAP; Schrijver, 2003), which identifies the globally optimal posi-
tional correspondences between the set of comets measured in frame t and 
the set of comets measured in frame t + 1. To render the assignment robust 
despite the substantial frame to frame displacements of comets, the comet 
positions in frame t are first projected into frame t + 1 using a Kalman filter 
(Jaqaman et al., 2008). Therefore, the assignment has to account only for 
the differences between projection and actual comet position at time point 
t + 1. Growth tracks with a lifetime of more than four frames are eliminated 
from further analysis.
To cluster collinear growth tracks that likely belong to the same MT, 
we again solve a LAP, here between the endpoints of terminating tracks 
and the start points of newly initiated tracks. A pairing between a track 
termination and a track initiation is considered only if these two events 
are separated by less than 30 frames; i.e., forward and backward gaps 
of a maximum of 15 s are allowed. Furthermore, the track initiation has to   
fall within either one of two cone-shaped, geometrical search regions 
(Fig. S3). The choice of the forward cone with an opening half-angle of 60° is   
motivated by the observation that during pauses or out of focus movements, 
MTs sometimes undergo significant lateral displacements and directional 
changes, especially at the cell periphery. The longer the gap duration, the 
larger is the probability for a lateral step and directional change. In con-
trast, the backward cone has an opening half-angle of 10° only, motivated 
by the observation that MT rescues generally follow the growth track before 
the catastrophe. The search space for possible pairings between growth 
track terminations and growth track initiations is also limited by a distance 
cutoff, which depends on the gap duration and the maximal anticipated 
speeds of MT growth and shrinkage. The latter are calculated from the 
initial speed distribution of the growth tracks and thus are automatically de-
termined by the software. All growth track pairings that pass these criteria 
participate then in the LAP. By construction, this assignment is spatially and 
temporally global, which warrants a high level of robustness. Competing 
pairings are weighed against one another via a cost function that prefers 
collinear track parings with a short gap distance (Matov et al., 2010). 
During the validation, it was noted that the selection of candidate track 
pairings tends to exclude a significant number of true pairings from the 
LAP. As a result, the analysis generates a relatively high fraction of false 
negatives; however, because of strict selection criteria, the number of false 
positives is low. Given the large number of trajectories harvested from these 
videos, the high number of false negatives is uncritical as long as they do 
not lead to a systematic exclusion of certain forward and background gap 
events. In Matov et al. (2010), it is shown that with the parameter settings 
described  in  this  study,  computer-generated  distributions  of  growth  and 
shrinkage speeds as well as pause frequencies and duration are statisti-
cally identical to the same distributions extracted from manual tracking of 
-tubulin–labeled MTs.
Merging of data from multiple videos per condition
For each condition, at least 15 videos containing one or two cells were 
acquired. Before merging the data for further statistical analysis, we de-
termined the video to video variation in the distributions of speeds and 
durations of growth, pause, and shrinkage events using the Kolmogorov- 
Smirnov  test.  Distributions  were  subsampled  to  400  values  to  avoid   
hypersensitivity of the Kolmogorov-Smirnov statistics. Videos passing the 
Proteins were run on 10–12% acrylamide gels, transferred to nitrocellulose 
membranes, and visualized by immunoblotting with following antibodies: 
rabbit anti–human pVHL
CT and rabbit anti–human pVHL
NT (1:500 dilution; 
Hergovich et al., 2003), anti-CDK-2 (1:1,000; Santa Cruz Biotechnology, 
Inc.), and anti–-tubulin YL1/2 (1:3,000; Harlan Laboratories).
Live cell imaging of EB3-GFP and GFP-CLIP170–expressing cells
Cells were distributed 24 h before video acquisition in 6-well plates con-
taining round coverslips (diameter 24 mm; #1.5) and cultured to 50% 
confluency  in  the  appropriate  medium  containing  25  mM  Hepes.  Cells 
on round coverslips were transferred to a homemade holding device, and   
600 µl of the appropriate medium was added. Videos were acquired with a 
microscope (IX70 Delta Vision Spectris; Olympus), temperature-controlled at 
37°C, using a 60× NA 1.4 differential interference contrast (DIC) oil Plan-
Apochromat objective and a camera (CoolSNAP HQ; Roper Industries) with 
an exposure time of 100 ms and a frame rate of 2 Hz. Acquisition software 
used  was  SoftWoRx  version  3.3.4  (Applied  Precision).  For  nocodazole   
experiments, a first video was acquired in 300 µl of normal growth me-
dium, and then 300 µl of growth medium containing 80 nM nocodazole 
was added, leading to a final concentration of 40 nM, and a video at 20, 
120, and 360 s after nocodazole addition was acquired from the very 
same position.
Live cell imaging of GFP-tubulin and manual tracking
RPE-1 cells stably expressing GFP–-tubulin (Rosa et al., 2006) were cul-
tured and prepared for live cell imaging the same way as RPE-1 EB3-GFP–
expressing cells. Videos were acquired as EB3-GFP videos except using a 
100× NA 1.4 DIC oil Plan-Apochromat objective with an exposure time   
of 200 ms and a frame rate of 0.5 Hz. From these acquired videos, MTs 
were manually tracked using SoftWoRx version 3.3.4. Intervals with a ve-
locity <0.1 µm/s were defined as a pause events. Videos were acquired in 
two independent sessions, and manual tracking was performed on 20 MTs 
in at least three different cells per condition from each session.
Immunofluorescence and measurement of GTP-tubulin remnants
Immunofluorescence  staining  of  tubulin  and  GSK-3  was  performed  as 
previously described (Thoma et al., 2007) using monoclonal GSK-3 anti-
body (1:200; BD) and a polyclonal antibody recognizing -tubulin (1:400;   
Abcam) and using a confocal microscope (SP2-AOBS; Leica) with a 63× NA 
1.4 oil HCX Plan-Apochromat objective. Signal intensities were measured 
for each channel using ImageJ software (National Institutes of Health).
For GTP-tubulin staining, RCC-4 cells were distributed on glass cover-
slips and processed for costaining with a monoclonal antibody recogniz-
ing GTP-tubulin (hMB11; 1:200; Dimitrov et al., 2008) and a polyclonal 
antibody recognizing -tubulin (1:400; Abcam) as described previously 
(Dimitrov et al., 2008). Stacks from randomly chosen cells were acquired 
with an IX70 Delta Vision Spectris microscope using a 60× NA 1.4 DIC 
Oil Plan-Apochromat objective. After deconvolution using SoftWoRx ver-
sion 5.3.1, >20 distances between GTP remnants were measured per cell 
from peripheral MTs, where remnants were clearly resolved and assigned 
to the same MT, using SoftWoRx version 5.3.1. Remnant density in the 
perinuclear cell region was determined by the area density of fluorescence 
accumulated in a manually selected region using ImageJ software.
In vitro MT GTPase assay
Cloning and purification of GST, GST-VHL30, and GST-VHL30,95–123 fusion 
proteins has been described previously (Hergovich et al., 2006). EasyRad 
phosphate assay biochem kit (Cytoskeleton, Inc.) was used to measure the 
release of 
32P from -[
32P]GTP (Hartmann Analytic) from MAP-rich tubu-
lin (Cytoskeleton, Inc.) supplemented with GST fusion proteins. A reaction 
mix was prepared containing 1 mg ml
1 MAP-rich tubulin, 10 µM GTP,   
20 nM -[
32P]GTP, and 0.5 µM GST fusion protein in 100 µl reaction buffer 
(EasyRad phosphate assay) and incubated at 37°C. Aliquots of 10 µl were 
taken at the indicated time points, put into 400 µl of separator solution 
(EasyRad phosphate assay), and put on ice. An aliquot to measure the 
background value was taken 10 s after incubation at 37°C and put into 
400 µl of separator solution, and an aliquot was added at the end to 400 µl   
double distilled H2O to measure total activity. Collected samples were centri-
fuged at 14,000 rpm for 10 min, and 200 µl of the supernatant was mea-
sured in a scintillation counter (LS 6500; Beckman Coulter).
Image analysis
All image analysis programs for detection of individual EB3 features, fea-
ture tracking, clustering of growth tracks, parsing of MT trajectories for ex-
traction of MT dynamics, statistical analysis of MT dynamics, and graphical 
representation of the results were developed in MATLAB (MathWorks) JCB • VOLUME 190 • NUMBER 6 • 2010   1002
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consistency test were included in the final datasets. The number of mutually 
consistent videos per dataset is documented in Tables S2–S5.
Statistical analyses of parameters of MT dynamics
Statistical comparison of MT dynamics between different conditions was ac-
complished in two steps for the distributions of growth, pause, and shrink-
age speed distributions. First, we examined whether the different conditions 
would profoundly change the distribution, which would indicate an entirely 
different state of MT regulation between conditions. To test this possibility, 
we aligned the distributions of compared conditions at their respective 
mean value and then applied the nonparametric Kolmogorov-Smirnov test 
to determine whether the two distributions are identical. The distributions 
were randomly subsampled to 400 values. The subsampling was repeated 
200 times, and the final p-values were derived by averaging.
In a second step, we compared the shifts in parameter mean values 
between different conditions. To achieve this, we calculated the mean of a 
specific parameter, e.g., growth speed, per video. Then we tested normal-
ity of the distribution of the means and applied the Student’s t test to define 
the significance of parameter changes between conditions (mean ± SEM 
of cell to cell variation). This test assumes that the cell to cell variation is the 
single biggest source of variation in the mean value of a condition.
For the comparison of manually tracked parameters of MT dynam-
ics between nonsilenced and VHL-silenced RPE-1 cells, the dataset was 
not sufficiently large enough to follow the aforementioned test procedures. 
Instead, we used the permutation t test (Hesterberg et al., 2005), which 
compares the bootstrapped distributions of a parameter in condition 1 
versus condition 2. This test does not make any assumption about the char-
acteristic of the tested distribution and thus is appropriate for application 
to the distributions of growth and shrinkage speeds and of growth, pause, 
and shrinkage times, which are far from being normally distributed.
Online supplemental material
Fig. S1 shows manual GFP-tubulin tracking in RPE-1 cells depleted for VHL 
and comparison of automated tracking of EB3-GFP and GFP-CLIP170 as 
markers of MT growth. Fig. S2 shows colocalization of pVHL and EB3 
comets in RPE-1 cells. Fig. S3 schematically explains the grouping of MT 
growth tracks. Fig. S4 provides additional analysis of naturally occurring 
VHL point mutants. Fig. S5 shows the purification of GST fusion proteins 
for the GTPase assay. Video 1 shows detection of EB3-GFP comets in RPE-1   
cells.  Video  2  illustrates  the  large  number  and  high  density  of  tracked   
EB3-GFP comets captured for a single RCC-4 cell in a typical time-lapse 
video. Videos 3 and 4 illustrate in an overview and zoomed version the 
comet tracking and growth track grouping that allow inference of param-
eters of MT dynamics in RPE-1 cells. Video 5 compares the number of EB3-
GFP comets detected after nocodazole perturbation in a cell without and 
with active VHL. Tables S1–S5 provide all of the parameters of MT dynamics 
extracted by tracking of GTP-tubulin (Table S1) and EB3-GFP (Tables S2–S5). 
Online  supplemental  material  is  available  at  http://www.jcb.org/cgi/ 
content/full/jcb.201006059/DC1.
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